Interaction of heparin with β2-glycoprotein I and antiphospholipid antibodies in vitro
- 15 December 1992
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 68 (6) , 495-500
- https://doi.org/10.1016/0049-3848(92)90063-g
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Immunology and Clinical Importance of Antiphospholipid AntibodiesPublished by Elsevier ,1991
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Antiphospholipid Antibodies and Recurrent Pregnancy LossAmerican Journal of Reproductive Immunology, 1989
- Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan SulfateaAnnals of the New York Academy of Sciences, 1989
- The relationship between lupus anticoagulants and antibodies to phospholipidJAMA, 1988
- Inhibitors of Complement‐Mediated Cytotoxicity in Normal and Secondary Aborter SeraAmerican Journal of Reproductive Immunology, 1986
- beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathwayBlood, 1985
- β2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesiclesInternational Journal of Biochemistry, 1984
- Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activityCellular Immunology, 1983
- Binding of β2-glycoprotein I to platelets: Effect of adenylate cyclase activityThrombosis Research, 1980